IGM Biosciences, Inc.
IGMS
$1.25
$0.054.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.89M | -36.65M | -61.43M | -47.90M | -49.82M |
| Total Depreciation and Amortization | 2.27M | 2.35M | 2.31M | 2.28M | 2.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.60M | 6.30M | 17.14M | 9.15M | 8.21M |
| Change in Net Operating Assets | -9.50M | -6.83M | 3.60M | -896.00K | -2.98M |
| Cash from Operations | -32.52M | -34.82M | -38.39M | -37.37M | -42.42M |
| Capital Expenditure | -31.00K | -862.00K | -1.29M | -1.21M | -2.48M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 7.00K | 32.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.77M | 18.86M | 14.27M | 25.71M | 11.14M |
| Cash from Investing | 42.74M | 18.00M | 12.99M | 24.52M | 8.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.00K | 420.00K | 1.20M | 648.00K | 191.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -32.00K | -39.00K |
| Cash from Financing | 5.00K | 420.00K | 1.20M | 615.00K | 152.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.22M | -16.40M | -24.20M | -12.24M | -33.61M |